Locally Applied Pressure-induced Vasodilatation

Vascular Diseases Clinical Trial

— LAV  

Official title:

Réponse à l'Application d'Une Pression Locale en Laser Speckle Imaging Locally Applied Pressure-induced Vasodilatation

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02861924
• Other study ID #: 2016-A00609-42
• Status: Completed
• Phase: N/A
• Start date: October 11, 2016
• Est. completion date: March 31, 2019

Study information

• Verified date: November 2019
• Source: University Hospital, Angers
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Measure microcirculatory responses after localized ischemia obtained by local application of pressure (laser speckle).

Description:

Measure microcirculatory responses after localized ischemia obtained by local application of pressure (laser speckle). The purpose of this study is to perform measurements of the methodological points made.

The study will investigate :

• The effect of the duration and intensity of the pressure

• The reproducibility of measurements

• The correlation with ischemic hyperemia post

Recruitment information / eligibility

• Status: Completed
• Enrollment: 45
• Est. completion date: March 31, 2019
• Est. primary completion date: March 31, 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• subjects without vascular pathology

Exclusion Criteria:

• pregnancy

• allergy tape

Related Conditions & MeSH terms

• Vascular Diseases

Intervention

Other:
• microcirculatory responses
The effect of the duration and intensity of the pressure; reproducibility and correlation with ischemic hyperemia post. measurements are made with the Imager SPECKLE imager (LSCI) give the microvascular perfusion data in arbitrary units called perfusion units (UP).

Locations

Country	Name	City	State
France	CHU Angers	Angers

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Angers

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	microcirculatory response to local pressure. Measurements are made with the Imager SPECKLE imager (LSCI) give the microvascular perfusion data in arbitrary units called perfusion units (UP).	Measurements are made with the Imager SPECKLE imager (LSCI) give the microvascular perfusion data in arbitrary units called perfusion units (UP).	2 hours